Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
22,050 results
  • Rapid infusion rituximab is well tolerated in patients with primary CNS lymphoma. [Journal Article]
  • COCNS Oncol 2018 Sep 17
  • Modelevsky L, Tizon R, … Kaley T
  • CONCLUSIONS: 11 patients received a total of 44 RRIs. Rituximab was dosed at 500 or 750 mg/m2. Premedication included acetaminophen and diphenhydramine. No infusion reactions occurred during any RRI. Two infusions were administered with steroids for neurologic symptoms at baseline (4.5%). Rapid administration of rituximab was safe and feasible for patients with PCNSL and at the higher doses received.
  • Acute Appendicitis: Efficient Diagnosis and Management. [Journal Article]
  • AFAm Fam Physician 2018 Jul 01; 98(1):25-33
  • Snyder MJ, Guthrie M, Cagle S
  • Appendicitis is one of the most common causes of acute abdominal pain in adults and children, with a lifetime risk of 8.6% in males and 6.7% in females. It is the most common nonobstetric surgical em...
  • Lixisenatide reduces chylomicron triacylglycerol due to increased clearance. [Journal Article]
  • JCJ Clin Endocrinol Metab 2018 Sep 11
  • Whyte MB, Shojaee-Moradie F, … Umpleby AM
  • CONCLUSIONS: Lixisenatide reduced [13C]oleate concentration, derived from a single meal in CM-TAG, as well as glucose Rameal, through delayed gastric emptying. However day-long CM production, measured with repeated meal-feeding, was not reduced by lixisenatide and decreased CM-TAG concentration was due to increased CM-TAG clearance.
New Search Next